|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| C07K 14/52 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2105449 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08010991.1 |
| Date of filing the European patent application | 2001-02-23 | |
| (97) | Date of publication of the European application | 2009-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
| (46) | Date of publication of the claims translation | 2019-08-12 |
| (30) | Number | Date | Country code |
| 511139 | 2000-02-23 | US | |
| 791153 | 2001-02-22 | US |
| (72) |
Deshpande, Rajendra V., US
Hitz, Anna, US
Boyle, William J., US
Sullivan, John K., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Osteoprotogerino rišimosi baltymo antagonistiniai selektyvūs rišimosi agentai |
| Antagonistic selective binding agents of osteoprotegerin binding protein |
| Payment date | Validity (years) | Amount | |
| 2020-01-31 | 20 | 347.00 EUR |